You can Subscribe to our RSS FEED:
which delivers brain tumor news and additions
to the website via RSS.
Click HERE for details on RSS.
Displaying items 26 to 50 of about 5242
Veliparib + RT + TMZ in Patients With Unmethylated MGMT Glioblastoma
Oncolytic Virus Teserpaturev Approved in Japan for Malignant Glioma
Promising New Legislation Could Transform the FDA`s Drug Approval Process, Leading to Better Treatments and Lower Prices
Combination chemotherapy versus temozolomide for patients with methylated MGMT (m-MGMT) glioblastoma: results of computational biological modeling to predict the magnitude of treatment benefit
Y-mAbs Announces Update on Omburtamab for DIPG
Musella Foundation awards two more brain tumor research grants!
Market Research Opportunity for Patients and Caregivers
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma
Important Brain Tumor webinar tonight Sunday 5/30/21 7pm Eastern
Novocure Announces Clinical Trial Collaboration with GT Medical Technologies to Evaluate Tumor Treating Fields Together with GammaTile® Therapy in Recurrent Glioblastoma
Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma
Japan to approve virotherapy drug for 1st time for cancer treatment
Musella Foundation awards three brain tumor research grants!
Brain Tumor Webinar Tonight (Sunday 5/23/21 at 7pm Eastern)
A randomized phase II trial of veliparib, radiotherapy and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study
Navigated repetitive transcranial magnetic stimulation improves the outcome of postsurgical paresis in glioma patients – A randomized, double-blinded trial
Webinar recordings posted to our brain tumor video library!
The Promising Pathway Act was reintroduced in the Senate on May 13, 2021
Mustang Bio and City of Hope Announce First Patient Dosed in Phase 1 Clinical Trial of MB-101 (IL13Ra2-specific CAR T cells) to Treat Leptomeningeal Brain Tumors
GT Medical Technologies Announces First Patient Has Been Enrolled In Clinical Trial Evaluating GammaTile® Therapy In Patients With Metastatic Brain Tumors
Brain Tumor Webinar Tonight (Sunday 5/16/21 7pm Eastern)
The Glioblastoma Research Organization Launches Project Rush in Proud Partnership With Lenox Hill Hospital
UK Manufacturing Facility & Phase III Trial Updates From Northwest Biotherapeutics
Tumor-treating fields (TTFields)-based cocktail therapy: a novel blueprint for glioblastoma treatment
Foucused Ultrasound Webinar added to our video library!
Brain Tumor News Blast
Enter your email address to subscribe!
Copyright © 1993 - 2021 Musella Foundation- All Rights Reserved.
Website by LcsProductionDesign.com